SSNC Stock Analysis: SS&C Technologies Holdings | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 18.864m USD | 12M Return: -6.6% | US78467J1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 140M
EPS Trend: 99.6%
Qual. Beats: 1
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SS&C Technologies Holdings, Inc. is a global provider of software products and software-enabled services primarily serving the financial services and healthcare industries. The company operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific, offering technology that spans the full investment lifecycle, including front-office functions (trading and modeling), middle-office functions (portfolio management and reporting), and back-office functions (accounting, reconciliation, processing and clearing, compliance, and tax reporting). It also delivers healthcare solutions covering claims adjudication, benefit management, care management, and business intelligence.
In addition to its core software platform, SS&C provides software-enabled services such as SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Calastone, Managed Services, Data Solutions, ALPS Advisors, and Virtual Data Rooms, along with pharmacy and healthcare administration solutions. The company supplements these offerings with professional services, including consulting, implementation, system installation, data conversion, training, and product support. Founded in 1986 and headquartered in Windsor, Connecticut, SS&C is classified within the Application Software sub-industry of the Information Technology sector, a segment typically characterized by a mix of licensed software and recurring, services-based revenue streams.
- Alternative asset manager AUM growth lifts recurring software fees
- Acquisition integration continues expanding adjusted operating margins
- Higher interest rates inflate servicing costs on acquisition debt
| Net Income: 852.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.62 > 1.0 |
| NWC/Revenue: -23.29% < 20% (prev 9.02%; Δ -32.31% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.87b > Net Income 852.9m |
| Net Debt (7.33b) to EBITDA (2.24b): 3.27 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (240.6m) vs 12m ago -4.94% < -2% |
| Gross Margin: 48.21% > 18% (prev 48.56%; Δ -0.35% > 0.5%) |
| Asset Turnover: 33.51% > 50% (prev 31.55%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: 3.51 > 6 (EBIT TTM 1.51b / Interest Expense TTM 431.0m) |
| A: -0.08 (Total Current Assets 5.65b - Total Current Liabilities 7.21b) / Total Assets 20.4b |
| B: 0.20 (Retained Earnings 4.18b / Total Assets 20.4b) |
| C: 0.08 (EBIT TTM 1.51b / Avg Total Assets 20.0b) |
| D: 0.49 (Book Value of Equity 6.70b / Total Liabilities 13.6b) |
| Altman-Z'' = 1.19 = BB |
| DSRI: 0.21 (Receivables 1.09b/4.69b, Revenue 6.69b/6.15b) |
| GMI: 1.01 (GM 48.56% / 48.21%) |
| AQI: 1.00 (AQ_t 0.70 / AQ_t-1 0.70) |
| SGI: 1.09 (Revenue 6.69b / 6.15b) |
| TATA: -0.05 (NI 852.9m - CFO 1.87b) / TA 20.4b) |
| Beneish M = -3.61 (Cap -4..+1) = AAA |
As of November 08, 2026, the stock is trading at USD 77.71 with a total of 3,113,543 shares traded. Over the past week, the price has changed by -3.33%, over one month by -0.36%, over three months by -2.31% and over the past year by -6.57%.
Current recommended Stop Loss: 75.00 (which is 3.5% or 1.3 ATR below the current price).
SS&C Technologies Holdings has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy SSNC.
- StrongBuy: 5
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 98.6 | 26.8% |
P/E Trailing = 23.2341
P/E Forward = 10.5597
P/S = 2.8213
P/B = 2.8241
P/EG = 0.6993
Revenue TTM = 6.69b USD
EBIT TTM = 1.51b USD
EBITDA TTM = 2.24b USD
Long Term Debt = 7.41b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.26b USD (from shortTermDebt, last quarter)
Debt = 7.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 200.1m
Net Debt = 7.33b USD (calculated: Debt 7.86b - CCE 525.4m)
Enterprise Value = 26.2b USD (18.9b + Debt 7.86b - CCE 525.4m)
Interest Coverage Ratio = 3.51 (Ebit TTM 1.51b / Interest Expense TTM 431.0m)
EV/FCF = 14.89x (Enterprise Value 26.2b / FCF TTM 1.76b)
FCF Yield = 6.72% (FCF TTM 1.76b / Enterprise Value 26.2b)
FCF Margin = 26.32% (FCF TTM 1.76b / Revenue TTM 6.69b)
Net Margin = 12.76% (Net Income TTM 852.9m / Revenue TTM 6.69b)
Gross Margin = 48.21% ((Revenue TTM 6.69b - Cost of Revenue TTM 3.46b) / Revenue TTM)
Gross Margin QoQ = 48.15% (prev 48.26%)
Tobins Q-Ratio = 1.28 (Enterprise Value 26.2b / Total Assets 20.4b)
Interest Expense / Debt = 5.49% (Interest Expense 431.0m / Debt 7.86b)
Taxrate = 21.97% (240.4m / 1.09b)
NOPAT = 1.18b (EBIT 1.51b * (1 - 21.97%))
Current Ratio = 0.78 (Total Current Assets 5.65b / Total Current Liabilities 7.21b)
Debt / Equity = 1.17 (Debt 7.86b / totalStockholderEquity, last quarter 6.70b)
Debt / EBITDA = 3.27 (Net Debt 7.33b / EBITDA 2.24b)
Debt / FCF = 4.17 (Net Debt 7.33b / FCF TTM 1.76b)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.27% (Net Income 852.9m / Total Assets 20.4b)
RoE = 12.60% (Net Income TTM 852.9m / Total Stockholder Equity 6.77b)
RoCE = 10.66% (EBIT 1.51b / Capital Employed (Equity 6.77b + L.T.Debt 7.41b))
RoIC = 7.79% (NOPAT 1.18b / Invested Capital 15.1b)
WACC = 6.50% (E(18.9b)/V(26.7b) * Re(7.43%) + D(7.86b)/V(26.7b) * Rd(5.49%) * (1-Tc(0.22)))
Discount Rate = 7.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.91 | Cagr: -2.09%
[DCF] Terminal Value 77.97% ; FCFF base≈1.60b ; Y1≈1.84b ; Y5≈2.70b
[DCF] Fair Price = 142.0 (EV 40.6b - Net Debt 7.33b = Equity 33.3b / Shares 234.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.65 | EPS CAGR: 14.90% | SUE: 2.64 | # QB: 1
Revenue Correlation: 99.75 | Revenue CAGR: 7.31% | SUE: 0.41 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.87 | Chg30d=+0.56% | Revisions=+50% | Analysts=8
EPS current Year (2026-12-31): EPS=7.14 | Chg30d=+1.04% | Revisions=+73% | GrowthEPS=+16.3% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=7.73 | Chg30d=+0.04% | Revisions=+55% | GrowthEPS=+8.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +73% (up=21, down=2)